Emma Nolan

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 3

Top Topics

Combination Therapy

Tyrosine Kinase

Cancer Stem Cells

Top Venues

Journal of liposome research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Gao, Andrew N Shelling, Emma Nolan, David Porter, Euphemia Y Leung, Zimei Wu
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells. Journal of liposome research (2024)
Yu Gao, Andrew N Shelling, Emma Nolan, David Porter, Euphemia Y Leung, Zimei Wu
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells. Journal of liposome research 34 (3) (2024)
Emma Nolan, Peter Savas, Antonia N Policheni, Phillip K Darcy, François Vaillant, Christopher P Mintoff, Sathana Dushyanthen, Mariam Mansour, Jia-Min B Pang, Stephen B Fox, null null, Charles M Perou, Jane E Visvader, Daniel H D Gray, Sherene Loi, Geoffrey J Lindeman
Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer. Science translational medicine 9 (393) (2018)